Pages that link to "Q34386219"

The following pages link to Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake (Q34386219):

Displaying 28 items.

• Malignant melanoma and melanocortin 1 receptor. (Q33782773) (← links)
• Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides (Q34525161) (← links)
• Effects of the Amino Acid Linkers on the Melanoma-Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge–Cyclized α-MSH Peptides (Q34728904) (← links)
• Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides. (Q35169098) (← links)
• Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake (Q35187053) (← links)
• Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides (Q38637223) (← links)
• Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma (Q35985186) (← links)
• Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake (Q36230221) (← links)
• Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanoma (Q36346633) (← links)
• Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging (Q36737564) (← links)
• "Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system (Q37237829) (← links)
• Evaluation of new Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides for melanoma imaging (Q37399483) (← links)
• Effects of amino acids on melanoma targeting and clearance properties of Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides. (Q37432511) (← links)
• A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging (Q37491293) (← links)
• Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides (Q37584911) (← links)
• Radiometallated peptides for molecular imaging and targeted therapy. (Q37847064) (← links)
• Development of a (99m)Tc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors (Q38855639) (← links)
• Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging (Q38921308) (← links)
• Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptide (Q39183267) (← links)
• Substitution of Gly with Ala enhanced the melanoma uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide. (Q39403093) (← links)
• Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids. (Q39672404) (← links)
• Preclinical Melanoma Imaging with 68Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET. (Q41837537) (← links)
• Effects of the Arg-Pro and Gly-Gly-Nle Moieties on Melanocortin-1 Receptor Binding Affinities of α-MSH Peptides (Q42818237) (← links)
• Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor (Q47135383) (← links)
• Evaluation of novel 111In-labeled gonadotropin-releasing hormone peptides for human prostate cancer imaging (Q47792170) (← links)
• PET and SPECT imaging of melanoma: the state of the art. (Q47868574) (← links)
• Ga-DOTA-GGNle-CycMSH targets the melanocortin-1 receptor for melanoma imaging (Q58602911) (← links)
• Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting (Q91577077) (← links)